We are excited to attend Advanced Therapies Week in San Diego. It is one of the leading biotech partnering events in the U.S. where leaders across research, development, and manufacturing come together to shape the future of the cell and gene therapy ecosystem. Come meet our team and discover how Biocytogen is helping drive innovation in the industry.
What is Advanced Therapies Week?
Advanced Therapies Week brings together 2,000 industry leaders for a dynamic four day program featuring expert-led panels, roundtable talks, and workshops. Attendees will explore emerging trends in advanced therapies, including the growing role of AI, cross-cultural teams, and sustainable biotech ecosystems. This is the place to connect, collaborate, and advance the future of advanced therapies.
Event Overview
Date: February 9th - 12th, 2026
Venue: San Diego Convention Centre, 111 W. Harbor Drive, San Diego, CA
Event Schedule
For more information, please refer to the event agenda.
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to meeting you in San Diego!
